Virbac has acquired Thyronorm (thiamazole), the leading treatment for feline hyperthyroidism, from Norbrook. 

Marketed since 2016, Thyronorm is an award-winning liquid formulation that simplifies administration compared to tablets and enables precise dosing for both veterinary surgeons and pet owners.

During the product handover veterinary practices can continue to buy Thyronorm from their usual wholesaler, and all practice support activities and retrospective commercial rebates remain unchanged.

Virbac says it is working closely with Norbrook to make sure all practice support activities are smoothly handed over from Norbrook Account Managers to Virbac Territory Managers.

https://uk.virbac.com

PS: Whilst you're here, take a moment to see our latest job opportunities for vet nurses.